does tirzepatide cause cancer and Cancer: What New Research Means for Your Health does tirzepatide cause cancer Comparative

Recent genetic and biochemical studies suggest that the dysregulated metabolic mediators released by adipose tissue including adipokines, cytokines, chemokines, excess lipids and toxic lipid metabolites promote IR in other tissues

More than 12 million Americans take a prescription GLP-1 treatment like Wegovy, Ozempic, or Zepbound

Oshiro K, Koizumi M, Maruyama H, et al

Many medical teams need to provide recent medication start dates, dose adjustments and anticipated effects on appetite and weight

Rather than previously storing subcutaneous fat (fat stored just below the skin) typically in the hips and thighs, the body starts accumulating visceral fat, or body fat stored deep in the abdomen that carries significant health risks

Its a different medication than tirzepatide (GLP-1 only vs dual GIP/GLP-1 activity), and it is not FDA-approved as of the latest update in our review: Orforglipron: The New Oral GLP-1 Drug Explained